Depreciation, Depletion and Amortization in USD of GeneDx Holdings Corp. from 2019 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
Summary
GeneDx Holdings Corp. quarterly/annual Depreciation, Depletion and Amortization history and change rate from 2019 to Q3 2025.
  • GeneDx Holdings Corp. Depreciation, Depletion and Amortization for the quarter ending 30 Sep 2025 was $2.37M, a 2.15% decline year-over-year.
  • GeneDx Holdings Corp. Depreciation, Depletion and Amortization for the twelve months ending 30 Sep 2025 was $8.85M, a 4.71% increase year-over-year.
  • GeneDx Holdings Corp. annual Depreciation, Depletion and Amortization for 2024 was $7.9M, a 59.9% decline from 2023.
  • GeneDx Holdings Corp. annual Depreciation, Depletion and Amortization for 2023 was $19.7M, a 60.6% decline from 2022.
  • GeneDx Holdings Corp. annual Depreciation, Depletion and Amortization for 2022 was $50M, a 129% increase from 2021.
Depreciation, Depletion and Amortization, Trailing 12 Months (USD)
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Change (%)
Depreciation, Depletion and Amortization, Annual (USD)
Depreciation, Depletion and Amortization, YoY Annual Change (%)

GeneDx Holdings Corp. Quarterly Depreciation, Depletion and Amortization (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $8.85M $2.37M -$52K -2.15% 01 Jul 2025 30 Sep 2025 10-Q 28 Oct 2025
Q2 2025 $8.9M $2.29M +$574K +33.5% 01 Apr 2025 30 Jun 2025 10-Q 29 Jul 2025
Q1 2025 $8.33M $2.17M +$430K +24.7% 01 Jan 2025 31 Mar 2025 10-Q 30 Apr 2025
Q4 2024 $7.9M $2.02M -$554K -21.5% 01 Oct 2024 31 Dec 2024 10-K 20 Feb 2025
Q3 2024 $8.45M $2.42M -$2.74M -53.1% 01 Jul 2024 30 Sep 2024 10-Q 28 Oct 2025
Q2 2024 $11.2M $1.71M -$5.11M -74.9% 01 Apr 2024 30 Jun 2024 10-Q 29 Jul 2025
Q1 2024 $16.3M $1.74M -$3.39M -66% 01 Jan 2024 31 Mar 2024 10-Q 30 Apr 2025
Q4 2023 $19.7M $2.58M -$28M -91.6% 01 Oct 2023 31 Dec 2023 10-K 20 Feb 2025
Q3 2023 $47.7M $5.17M -$1.83M -26.1% 01 Jul 2023 30 Sep 2023 10-Q 29 Oct 2024
Q2 2023 $49.5M $6.83M +$199K +3% 01 Apr 2023 30 Jun 2023 10-Q 30 Jul 2024
Q1 2023 $49.3M $5.13M -$673K -11.6% 01 Jan 2023 31 Mar 2023 10-Q 29 Apr 2024
Q4 2022 $50M $30.6M +$24.8M +428% 01 Oct 2022 31 Dec 2022 10-K 23 Feb 2024
Q3 2022 $25.2M $7M +$1.5M +27.4% 01 Jul 2022 30 Sep 2022 10-Q 03 Nov 2023
Q2 2022 $23.7M $6.63M +$1.01M +17.9% 01 Apr 2022 30 Jun 2022 10-Q 08 Aug 2023
Q1 2022 $22.7M $5.8M +$901K +18.4% 01 Jan 2022 31 Mar 2022 10-Q 09 May 2023
Q4 2021 $21.8M $5.8M 01 Oct 2021 31 Dec 2021 10-K 16 Mar 2023
Q3 2021 $5.49M +$2.42M +79% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022
Q2 2021 $5.62M 01 Apr 2021 30 Jun 2021 10-Q 15 Aug 2022
Q1 2021 $4.9M 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022
Q3 2020 $3.07M 01 Jul 2020 30 Sep 2020 10-Q 15 Nov 2021

GeneDx Holdings Corp. Annual Depreciation, Depletion and Amortization (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $7.9M -$11.8M -59.9% 01 Jan 2024 31 Dec 2024 10-K 20 Feb 2025
2023 $19.7M -$30.3M -60.6% 01 Jan 2023 31 Dec 2023 10-K 20 Feb 2025
2022 $50M +$28.2M +129% 01 Jan 2022 31 Dec 2022 10-K 23 Feb 2024
2021 $21.8M +$10.1M +85.8% 01 Jan 2021 31 Dec 2021 10-K 16 Mar 2023
2020 $11.7M +$5.33M +83.1% 01 Jan 2020 31 Dec 2020 10-K 16 Mar 2023
2019 $6.41M 01 Jan 2019 31 Dec 2019 10-K 14 Mar 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.